Contact
Kristina Dinger
Head of People
career@adragos-pharma.com
About us
Adragos Pharma was founded in 2020 to build a leading global CDMO player in the Small Molecule space. We are pursuing an ambitious Buy&Build growth strategy: within the next three-five years, we will acquire and integrate pharmaceutical production sites in Europe and North America to become a market leader in the CDMO segment.
CDMOs (Contract Development and Manufacturing Organization), produce approx. 25% of drugs that are available in pharmacies and clinics, thus playing a vital role in medication access for millions of patients globally. Due to the increasing pressure on healthcare systems (aging population, prevalence of chronic disease, etc.), the importance of CDMOs is only going to grow.
Since 2020, we grew the team from three to more than 700 people, partnered with Scandinavian PE, FSN Capital, and a leading German Family Office, Prange Group. Until today, we acquired five production and development sites in Germany, France, Greece, Norway and Japan. You want to be part of our dynamic growth? Then apply now!